본문으로 건너뛰기
그룹별 보기 기록 1739건 · 페이지 4/35

사용금지 화장품 물질 — 부속서 II

부속서 II는 화장품 원료로 의도적으로 첨가하는 것이 금지된 물질을 나열합니다. 제17조는 별도로, 우수화장품제조관리기준(GMP)과 제3조의 안전 요건에 따라 기술적으로 피할 수 없는 비의도적 미량을 다룹니다. 이 페이지에는 기록 1739건이 있습니다.

이 부속서 필터링

이 부속서의 구성

Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.

  • 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
  • Prohibition covers intentional addition; there is no permitted concentration.
  • Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
  • Absence from Annex II is not permission — most substances appear in no annex at all.

Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.

The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.

Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.

The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.

대조 대상

부속서 II 기록

1739 총
이 목록의 기록, 총 1739건
항목물질CAS최대 농도표시
151Dinitrophenol isomersCAS 51-28-5 / 329-71-5 / 573-56-8 / 25550-58-7 51-28-5 / 329-71-5 / 573-56-8 / 25550-58-7 —
152Inproquone (INN)CAS 436-40-8 436-40-8 —
153Dimevamide (INN) and its saltsCAS 60-46-8 60-46-8 —
154Diphenylpyraline (INN) and its saltsCAS 147-20-6 147-20-6 —
155Sulfinpyrazone (INN)CAS 57-96-5 57-96-5 —
156N-(3-Carbamoyl-3,3-diphenylpropyl)-N,N-diisopropylmethylammonium salts, e.g. isopropamide iodide (INN)CAS 71-81-8 71-81-8 —
157Benactyzine (INN)CAS 302-40-9 302-40-9 —
158Benzatropine (INN) and its saltsCAS 86-13-5 86-13-5 —
159Cyclizine (INN) and its saltsCAS 82-92-8 82-92-8 —
1605,5-Diphenyl-4-imidazolidone (Doxenitoin (INN))CAS 3254-93-1 3254-93-1 —
161Probenecid (INN)CAS 57-66-9 57-66-9 —
162Disulfiram (INN)thiram (ISO) (INN)CAS 97-77-8 / 137-26-8 97-77-8 / 137-26-8 —
163Emetine, its salts and derivativesCAS 483-18-1 483-18-1 —
164Ephedrine and its saltsCAS 299-42-3 299-42-3 —
165Oxanamide (INN) and its derivativesCAS 126-93-2 126-93-2 —
166Eserine or physostigmine and its saltsCAS 57-47-6 57-47-6 —
1674-Aminobenzoic acid and its esters, with the free amino groupCAS 150-13-0 150-13-0 —
168Choline salts and their esters e.g. choline chloride (INN)CAS 67-48-1 67-48-1 —
169Caramiphen (INN) and its saltsCAS 77-22-5 77-22-5 —
170Diethyl 4-nitrophenyl phosphate (Paraoxon - ISO)CAS 311-45-5 311-45-5 —
171Metethoheptazine (INN) and its saltsCAS 509-84-2 509-84-2 —
172Oxpheneridine (INN) and its saltsCAS 546-32-7 546-32-7 —
173Ethoheptazine (INN) and its saltsCAS 77-15-6 77-15-6 —
174Metheptazine (INN) and its saltsCAS 469-78-3 469-78-3 —
175Methylphenidate (INN) and its saltsCAS 113-45-1 113-45-1 —
176Doxylamine (INN) and its saltsCAS 469-21-6 469-21-6 —
177Tolboxane (INN)CAS 2430-46-8 2430-46-8 —
1784-Benzyloxyphenol and 4-ethoxyphenolCAS 103-16-2 / 622-62-8 103-16-2 / 622-62-8 —
179Parethoxycaine (INN) and its saltsCAS 94-23-5 94-23-5 —
180Fenozolone (INN)CAS 15302-16-6 15302-16-6 —
181Glutethimide (INN) and its saltsCAS 77-21-4 77-21-4 —
182Ethylene oxideCAS 75-21-8 75-21-8 —CMR
183Bemegride (INN) and its saltsCAS 64-65-3 64-65-3 —
184Valnoctamide (INN)CAS 4171-13-5 4171-13-5 —
185Haloperidol (INN)CAS 52-86-8 52-86-8 —
186Paramethasone (INN)CAS 53-33-8 53-33-8 —
187Fluanisone (INN)CAS 1480-19-9 1480-19-9 —
188Trifluperidol (INN)CAS 749-13-3 749-13-3 —
189Fluoresone (INN)CAS 2924-67-6 2924-67-6 —
190Fluorouracil (INN)CAS 51-21-8 51-21-8 —
191Hydrofluoric acid, its normal salts, its complexes and hydrofluorides with exception of those given in Annex IIICAS 7664-39-3 7664-39-3 —
192Furfuryltrimethyl ammonium salts, e.g. furtrethonium iodide (INN)CAS 541-64-0 541-64-0 —
193Galantamine (INN)CAS 357-70-0 357-70-0 —
194Progestogens——
1951,2,3,4,5,6-Hexachlorocyclohexane (BHC-ISO)CAS 58-89-9 / - 58-89-9 / - —
196(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene (endrin - ISO)CAS 72-20-8 72-20-8 —
197HexachloroethaneCAS 67-72-1 67-72-1 —
198(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene (Isodrin-ISO)CAS 465-73-6 465-73-6 —
199Hydrastine, hydrastinine and their saltsCAS 118-08-1 / 6592-85-4 118-08-1 / 6592-85-4 —
200Hydrazides and their salts e.g. Isoniazid (INN)CAS 54-85-3 54-85-3 —

이 그룹별 보기 사용 방법

부속서 II에는 화장품에 사용이 금지된 물질이 포함되어 있습니다. 사용금지 물질 기록 1739건을 명칭, 식별자 및 연결된 항목 페이지별로 빠르게 훑어보려면 이 그룹별 보기를 이용하세요.

법적 문구 전문, 농도 논리, 경고 문구 또는 관련 식별자 링크가 필요하면 개별 기록을 여세요.